|
LOC728323 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.737700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.027640E-01 |
| Normal-vs-Stage2 |
3.377000E-01 |
| Normal-vs-Stage3 |
2.633000E-04 |
| Normal-vs-Stage4 |
2.983200E-04 |
| Stage1-vs-Stage2 |
9.604400E-01 |
| Stage1-vs-Stage3 |
1.227530E-02 |
| Stage1-vs-Stage4 |
1.264230E-02 |
| Stage2-vs-Stage3 |
8.216200E-02 |
| Stage2-vs-Stage4 |
7.635700E-02 |
| Stage3-vs-Stage4 |
7.744600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.024800E-03 |
| Normal-vs-AfricanAmerican |
6.419900E-02 |
| Normal-vs-Asian |
7.601000E-01 |
| Caucasian-vs-AfricanAmerican |
7.133600E-01 |
| Caucasian-vs-Asian |
2.960200E-01 |
| AfricanAmerican-vs-Asian |
3.394600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.644160E-03 |
| Normal-vs-Female |
6.489700E-02 |
| Male-vs-Female |
1.980580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.559400E-03 |
| Normal-vs-Age(41-60Yrs) |
6.148400E-02 |
| Normal-vs-Age(61-80Yrs) |
4.035300E-03 |
| Normal-vs-Age(81-100Yrs) |
8.787400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.563800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.267200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.593200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.921800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.405800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.785850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.819200E-01 |
| Normal-vs-Grade 2 |
2.767400E-01 |
| Normal-vs-Grade 3 |
3.799200E-04 |
| Normal-vs-Grade 4 |
1.435640E-03 |
| Grade 1-vs-Grade 2 |
8.305600E-01 |
| Grade 1-vs-Grade 3 |
1.669810E-01 |
| Grade 1-vs-Grade 4 |
1.690960E-01 |
| Grade 2-vs-Grade 3 |
3.103800E-03 |
| Grade 2-vs-Grade 4 |
1.536330E-02 |
| Grade 3-vs-Grade 4 |
7.769200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.550000E-01 |
| Normal-vs-ccB subtype |
8.440400E-03 |
| ccA subtype-vs-ccB subtype |
2.654200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.709680E-02 |
| Normal-vs-N1 |
2.647700E-02 |
| N0-vs-N1 |
4.461000E-01 |
|
|
